業(yè)執(zhí)照.jpg)
苦杏仁苷
分析標(biāo)準(zhǔn)品,HPLC≥98%
Amygdalin
CAS號(hào)：29883-15-6
分子式：C20H27NO11
分子量：457.43
MDL：MFCD00006598
別名：扁桃苷;苦杏仁甙
貨號(hào) | 規(guī)格/參數(shù)/品牌 | 價(jià)格 | 貨期 |
YJ-B20687-20mg | 分析標(biāo)準(zhǔn)品,HPLC≥98% | ￥200.00 | 現(xiàn)貨 |
YJ-B20687-100mg | 分析標(biāo)準(zhǔn)品,HPLC≥98% | ￥550.00 | 現(xiàn)貨 |
YJ-B20687-1g | 分析標(biāo)準(zhǔn)品,HPLC≥98% | ￥2500.00 | 現(xiàn)貨 |
JS30650-1g | BR，97% | ￥145.00 | 現(xiàn)貨 |
JS30650-5g | BR，97% | ￥180.00 | 現(xiàn)貨 |
JS30650-25g | BR，97% | ￥440.00 | 現(xiàn)貨 |
JS30650-100g | BR，97% | ￥1010.00 | 現(xiàn)貨 |
A10144-20mg | 分析標(biāo)準(zhǔn)品,含量93.1%，可溯源 | ￥480.00 | 現(xiàn)貨 |
產(chǎn)品介紹
扁桃素是從薔薇果實(shí)的果核中分離的植物葡萄糖苷，例如杏，桃，杏仁，櫻桃和李子。
熔點(diǎn)：223-226℃
沸點(diǎn)：743.3℃ at 760 mmHg
比旋光度：-38.5 o (C=4, H2O)
外觀：斜方柱狀結(jié)晶
溶解性：DMSO:≥75mg/mL(163.96mM)
H2O:50mg/mL(109.31mM;Needultrasonic)
儲(chǔ)存條件：2-8℃
注意：部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權(quán)威性，僅供客戶參考交流研究之用。
參考文獻(xiàn)(58篇)
58. [IF=7.6] Yujie Zhang et al."High-resolution mass spectrometry-based suspect and nontarget screening of natural toxins in foodstuffs and risk assessment of dietary exposure."ENVIRONMENTAL POLLUTION.2024 Nov;:125338
57. [IF=1.5] Ji Wanli et al."Revealing the Active Components and Therapeutic Targets of Sanao Decoction against Chronic Obstructive Pulmonary Disease Using Quantitative Analysis of Multi-Components by Single Marker and Network Pharmacology."JOURNAL OF CHROMATOGRAPHIC
56. [IF=4.8] Xiao Qiang et al."Flavonoids from Cerasus humilis seed coat alleviate constipation in mice: Role of AQP3/4 and c-Kit/SCF signaling pathways."Food Bioscience.2025 Jun;68:106643
55. [IF=5.3] Jiawei Bao et al."A novel efficient method for the simultaneous recycle of amygdalin and oil from bitter apricot kernels: Ultrasonication based on natural deep eutectic solvent."JOURNAL OF MOLECULAR LIQUIDS.2025 Jul;429:127592
54. [IF=5.3] Li Teng et al."Metabolomics integrated with network pharmacology of blood-entry constituents reveals the bioactive component of Xuefu Zhuyu decoction and its angiogenic effects in treating traumatic brain injury."Chinese Medicine.2024 Dec;19(1):1-16
53. [IF=6] Luyu Shan et al."Metabolism and release of characteristic components and profiles of enzymatic activities during fermentation of Massa Medicata Fermentata."LWT-FOOD SCIENCE AND TECHNOLOGY.2024 Oct;209:116793
52. [IF=5.3] Gao Jiaming et al."Buyang Huanwu decoction ameliorates myocardial injury and attenuates platelet activation by regulating the PI3 kinase/Rap1/integrin α(IIb)β(3) pathway."Chinese Medicine.2024 Dec;19(1):1-17
51. [IF=5] Luyao Liu et al."Targeted discovery of gut microbiome-remodeling compounds for the treatment of systemic inflammatory response syndrome."mSystems.
50. [IF=4.3] Hujun Du et al."Exploring the Underlying Mechanisms of Qingxing Granules Treating H1N1 Influenza Based on Network Pharmacology and Experimental Validation."Pharmaceuticals.2024 Jun;17(6):731
49. [IF=5.4] Yang Wang et al."Buyang huanwu decoction promotes remyelination via miR-760-3p/GPR17 axis after intracerebral hemorrhage."JOURNAL OF ETHNOPHARMACOLOGY".2024 Jun;328:118126
48. [IF=6] Dianwen Xu et al."Amygdalin Alleviates DSS-Induced Colitis by Restricting Cell Death and Inflammatory Response, Maintaining the Intestinal Barrier, and Modulating Intestinal Flora."Cells".2024 Jan;13(5):444
47. [IF=6] Rui Wang et al."Network Pharmacology-Based Approach reveals that Fructus mume exerts Therapeutic Effects against Ulcerative Colitis via the AGE/RAGE Signaling Pathway."Arabian Journal of Chemistry.2023 Dec;:105534
46. [IF=5.4] Menghan Cheng et al."A novel strategy of integrating network pharmacology and transcriptome reveals antiapoptotic mechanisms of Buyang Huanwu Decoction in treating intracerebral hemorrhage."JOURNAL OF ETHNOPHARMACOLOGY.10.1016/j.jep.2023.117123
45. [IF=5.4] Bo-Han Wang et al."Qufeng Xuanbi Formula inhibited benzo[a]pyrene-induced aggravated asthma airway mucus secretion by AhR/ROS/ERK pathway."JOURNAL OF ETHNOPHARMACOLOGY.10.1016/j.jep.2023.117203
44. [IF=5.4] Keyan Jiao et al."Glycosides of Buyang Huanwu decoction inhibits inflammation associated with cerebral ischemia-reperfusion via the PINK1/Parkin mitophagy pathway."JOURNAL OF ETHNOPHARMACOLOGY.2024 Jan;:117766
43. [IF=4.9] Zhang Min et al."Discovery and evaluation of active compounds from Xuanfei Baidu formula against COVID-19 via SARS-CoV-2 Mpro."Chinese Medicine.2023 Dec;18(1):1-14
42. [IF=5.4] Chang Zhou et al."Neuroprotective effects of Jie-du-huo-xue decoction on microglia pyroptosis after cerebral ischemia and Reperfusion——From the perspective of glial-vascular unit."JOURNAL OF ETHNOPHARMACOLOGY.2023 Aug;:116990
41. [IF=4.4] Mengyang Guo et al."Biotransformation of amygdalin by lactic acid bacteria fermentation."PROCESS BIOCHEMISTRY.2023 Sep;132:221
40. [IF=3.4] Wenmin Pi et al."Discovery, traceability, formation mechanism, metal and organic components analysis of supramolecules from Maxing Shigan decoction."JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS.2023 Sep;234:115532
39. [IF=2.745] Guoqin Zhang et al."Analysis of bitter almonds and processed products based on HPLC-fingerprints and chemometry."CHEMISTRY & BIODIVERSITY.2023 Feb;:
38. [IF=3.195] Yan, Fanchen et al."Glycoside combinations of Buyang Huanwu decoction ameliorate atherosclerosis via STAT3, HIF-1, and VEGF."NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY.2023 Jan;:1-17
37. [IF=6.056] Xianan Zhang et al."Effect of 1-methylcyclopropene on flat peach fruit quality based on electronic senses, LC-MS, and HS-SPME-GC-MS during shelf storage."LWT-FOOD SCIENCE AND TECHNOLOGY.2023 Jan;173:114388
36. [IF=2.65] Jing Zhou et al."Buyang Huanwu Decoction: A Traditional Chinese Medicine, Promotes Lactate-Induced Angiogenesis in Experimental Intracerebral Hemorrhage."Evidence-based Complementary and Alternative Medicine.2022 Oct 30;2022:4063315
35. [IF=5.168] Pan Wang et al."Discovery and characterization of novel ATP citrate lyase inhibitors from natural products by a luminescence-based assay."CHEMICO-BIOLOGICAL INTERACTIONS.2022 Nov;367:110199
34. [IF=5.988] Qihan Luo et al."Chang qing formula ameliorates colitis-associated colorectal cancer via suppressing IL-17/NF-κB/STAT3 pathway in mice as revealed by network pharmacology study."Frontiers in Pharmacology.2022; 13: 893231
33. [IF=6.656] Xinying Fu et al."Glycosides from Buyang Huanwu Decoction inhibit atherosclerotic inflammation via JAK/STAT signaling pathway."PHYTOMEDICINE.2022 Oct;105:154385
32. [IF=1.618] Zhang Guoqin et al."Study on the Correlation Between the Appearance Traits and Intrinsic Chemical Quality of Bitter Almonds Based on Fingerprint-Chemometrics."J Chromatogr Sci. 2022 Apr;:
31. [IF=2.193] Zhang Haibo et al.Systematic Study on a Quantitative Analysis of Multicomponents by Single Marker (QAMS) Method for Simultaneous Determination of Eight Constituents in Pneumonia Mixture by UPLC-MS/MS.J Anal Methods Chem. 2021;2021:8311588
30. [IF=3] Wan Haoyu et al."Pharmacokinetics of seven major active components of Mahuang decoction in rat blood and brain by LC–MS/MS coupled to microdialysis sampling."N-S Arch Pharmacol. 2020 Aug;393(8):1559-1571
29. [IF=3.935] Pengcheng Huang et al."Correlation study between the pharmacokinetics of seven main active ingredients of Mahuang decoction and its pharmacodynamics in asthmatic rats."J Pharmaceut Biomed. 2020 May;183:113144
28. [IF=4.225] Wei Wenyang et al."Screening of Antiviral Components of Ma Huang Tang and Investigation on the Ephedra Alkaloids Efficacy on Influenza Virus Type A."Front Pharmacol. 2019 Sep;0:961
27. [IF=1.773] Li-Hua ZHOU et al."Label-free quantitative proteomics reveals fibrinopeptide B and heparin cofactor II as potential serum biomarkers in respiratory syncytial virus-infected mice treated with Qingfei oral liquid formula."Chin J Nat Medicines. 2018 Apr;16:2
26. [IF=3.205] Dong-Dong Hu et al."Simultaneous determination of ten compounds in rat plasma by UPLC-MS/MS: Application in the pharmacokinetic study of Ma-Zi-Ren-Wan."J Chromatogr B. 2015 Sep;1000:136
25. [IF=3.414] Mengkai Zheng et al."Effects of herbal drugs in Mahuang decoction and their main components on intestinal transport characteristics of Ephedra alkaloids evaluated by a Caco-2 cell monolayer model."J Ethnopharmacol. 2015 Apr;164:22
24. Zheng, Mengkai, et al. "Effects of herbal drugs in Mahuang decoction and their main components on intestinal transport characteristics of Ephedra alkaloids evaluated by a Caco-2 cell monolayer model." Journal of ethnopharmacology 164 (2015): 22-29.https:##
23. Zhou, Li-Hua, et al. "Label-free quantitative proteomics reveals fibrinopeptide B and heparin cofactor II as potential serum biomarkers in respiratory syncytial virus-infected mice treated with Qingfei oral liquid formula." Chin J Nat Med 16 (2018): 241-25
22. Zhou, Li-Hua, et al. "Label-free quantitative proteomics reveals fibrinopeptide B and heparin cofactor II as potential serum biomarkers in respiratory syncytial virus-infected mice treated with Qingfei oral liquid formula." Chin J Nat Med 16 (2018): 241-25
21. 王盼,儲(chǔ)全根,軒云,蔡正銀.抵當(dāng)陷胸湯HPLC-MS指紋圖譜研究[J].時(shí)珍國(guó)醫(yī)國(guó)藥,2020,31(12):2937-2940.
20. 陳開(kāi)瓊,楊其芳,茍琪,呂燕,劉建利.枸杞枝葉中乳酸菌的分離及其在徒長(zhǎng)枝青貯中的應(yīng)用評(píng)價(jià)[J].中國(guó)農(nóng)業(yè)科技導(dǎo)報(bào),2021,23(02):193-201.
19. 薛夢(mèng)潔,于卉娟,王璐瑤,柴欣,楊靜,王躍飛.血府逐瘀湯提取過(guò)程中成分的量變規(guī)律研究[J].天津中醫(yī)藥,2021,38(01):109-112.
18. 王詩(shī)洋,王梟,徐祖清,劉悅,孔繁利.苦杏仁苷通過(guò)抑制氧化應(yīng)激及炎癥反應(yīng)減輕四氯化碳誘導(dǎo)的大鼠肝纖維化作用[J].現(xiàn)代免疫學(xué),2020,40(06):471-475+481.
17. 劉月波 章小敏 洪冰 等. HPLC-DAD法比較不同劑型麻黃湯及其拆方中有效成分含量[J]. 中國(guó)中醫(yī)藥科技 2020(1).
16. 萬(wàn)嘉洋, 田彥芳, 萬(wàn)海同,等. 麻黃湯有效組分配伍在發(fā)熱大鼠體內(nèi)的藥動(dòng)學(xué)研究[J]. 中國(guó)中藥雜志, 2019(10).
15. 馮倫元, 何臘平, 李翠芹,等. 貴州傳統(tǒng)發(fā)酵豆制品中水解銀杏黃酮苷的微生物β-葡萄糖苷酶篩選[J]. 微生物學(xué)報(bào), 2020(2).
14. 楊爽, 何妍茜, 楊潔,等. 感冒軟膠囊質(zhì)量標(biāo)準(zhǔn)提高的研究[J]. 時(shí)珍國(guó)醫(yī)國(guó)藥, 2013, 24(008):1930-1932.
13. 陳俊怡, 賈天柱. 對(duì)苦杏仁燀炒炮制意義的商榷[J]. 亞太傳統(tǒng)醫(yī)藥, 2012, 08(006):48-50.
12. 楊麗,李瑩,王清嫻,孫勇兵,劉灣,李文宏.麻黃-杏仁藥對(duì)配比與有效成分含量變化規(guī)律研究[J].中國(guó)當(dāng)代醫(yī)藥,2017,24(05):4-7+11.
11. 敖波, 侯永春, 賴珍珍,等. 麻黃-杏仁藥對(duì)成分-效應(yīng)間變化規(guī)律[J]. 中成藥, 2018(6).
10. 謝婧, 張志, 李聽(tīng)弦,等. 郁李仁不同炮制品及其水煎液中苦杏仁苷的含量比較[J]. 中國(guó)醫(yī)院藥學(xué)雜志, 2018(19).
9. 謝朝暉, 李鑫, 李文博,等. 超聲波法提取山杏仁中苦杏仁苷的單因素試驗(yàn)研究[J]. 河南城建學(xué)院學(xué)報(bào), 2012, 21(002):31-38.
8. 孫萌, 葉麗琴, 劉海嬌,等. 歐李種質(zhì)資源評(píng)價(jià)研究[J]. 中藥材, 2017, 40(001):54-57.
7. 卞曉坤, 錢(qián)大瑋, 段金廒,等. 桃仁與山桃仁化學(xué)成分比較研究[J]. 藥物分析雜志, 2020, 040(001):123-131.
6. 劉策, 2], 曹清明,等. 杏仁皮的苦杏仁苷含量測(cè)定及脫毒工藝探究[J]. 食品研究與開(kāi)發(fā), 2015(3):59-63.
5. 許照, 肖雄, 黃剛,等. 基于含藥腸吸收液的麻黃-杏仁藥對(duì)物質(zhì)基礎(chǔ)與作用機(jī)制分析[J]. 中國(guó)實(shí)驗(yàn)方劑學(xué)雜志, 2018, 024(006):1-6.
4. 陳銘中 鐘旭美 劉和平 等. 發(fā)酵青梅酒脫苦工藝的優(yōu)化[J]. 食品研究與開(kāi)發(fā) 2017(11):114-118.
3. 權(quán)博文 張慧文 劉廣達(dá) 等. 十種產(chǎn)地扁桃的HPLC指紋圖譜比較[J]. 中華中醫(yī)藥學(xué)刊 2018 36(12):2918-2921.
2. 劉瑞琛 劉冬科 李連 等. HPLC-MS/MS同時(shí)測(cè)定芪龍膠囊中6個(gè)有效成分的含量[J]. 藥物分析雜志 2020 v.40(05):36-42.
1. 李玲 張波 盧芳國(guó) 蔡亮 高強(qiáng) 胡玨 何谷良 吳濤.A型流感病毒對(duì)肺巨噬細(xì)胞自噬的影響及麻杏石甘湯含藥血清的干預(yù)作用[J].中國(guó)藥理學(xué)通報(bào) 2019 35(06):878-884.
從2011年開(kāi)始我們致力于在生命科學(xué)領(lǐng)域、生物醫(yī)學(xué)實(shí)驗(yàn)技術(shù)及論文潤(rùn)色服務(wù)，協(xié)助客戶各類實(shí)驗(yàn)服務(wù)及論文潤(rùn)色十余年，是客戶您值得信賴的科研合作伙伴!
如果您受時(shí)間、試驗(yàn)條件等限制而無(wú)法完成您的課題研究，歡迎您與我們聯(lián)系。
實(shí)驗(yàn)技術(shù)服務(wù)：
